The early symptoms are more frequent nocturnal urination, waiting for urination, and prolonged total urination time, and further development to difficult urination, thin urine line, short range, and incomplete dripping. The first step in the diagnosis and treatment of prostate enlargement is to systematically evaluate the condition and develop an effective treatment plan. ultrasound, urine flow rate, blood PSA and other tests can effectively help doctors understand the progress of the patient’s disease. Depending on the condition, medication is often applied first, mainly including a receptor blockers, 5a reductase inhibitors and botanicals. However, single drug therapy is more solidified and lacks individualized treatment for patients with different symptoms. In recent years, our research has found that common treatment protocols can no longer meet the diverse and variable disease characteristics of modern elderly prostate patients. The symptoms are variable, and the disease ranges from mild to severe, so individualized programs need to be developed. The treatment methods and cycles vary and are very different, depending on whether the symptoms are mainly in the storage phase (frequent urination, urgent urination, nocturnal urination) or in the voiding phase (difficult urination, thin urine line, waiting for urination, incomplete urination) or both. Among these patients, 5% of them have the same symptoms as prostate enlargement but are occult prostate cancer. It needs to be determined by an experienced specialist by checking the anal finger, transrectal prostate ultrasound, and checking the blood PSA. For more than a decade, medications for prostate enlargement have made great strides, allowing most patients to have their disease controlled and their quality of life improved. However, when BPH is combined with complications such as hydronephrosis, urinary retention, infection, and bladder stones, surgical treatment remains the only effective treatment. Holmium laser prostate enucleation combines the advantages of high-tech technology and anatomical enucleation, which can completely prostate, but also has less bleeding, no complications such as electrodesiccation syndrome, and is considered the most promising method for treating prostate enlargement and a micro-innovative technology worth developing and promoting. Holmium laser minimally invasive surgery has shown its superiority and is gradually replacing the previous electrodesiccation with more precise efficacy, less complications and minimal bleeding It has enabled more patients who were previously unable to undergo electrodesiccation to be treated, especially those who were previously considered inoperable due to their advanced age and high risk, allowing these patients to get rid of their urinary catheters and return to normal life and work. Although this technology is currently limited to individual hospital applications, it is believed that in the near future it will be widely accepted and promoted for the benefit of the majority of patients.